Back
Cidara Therapeutics 10K Form
Buy
81
CDTX
Cidara Therapeutics
Last Price:
20.68
Seasonality Move:
12.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDTX News And Ratings
See the #1 stock for the next 7 days that we like better than CDTX
CDTX Financial Statistics
Sales & Book Value
Annual Sales: | $63.91M |
---|---|
Cash Flow: | $-36.8M |
Price / Cash Flow: | 0 |
Annual Sales: | $16.41 |
Price / Book: | 1.06 |
Profitability
EPS (TTM): | -25.36000 |
---|---|
Net Income (TTM): | $-120.73M |
Gross Margin: | $62.38M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Cidara Therapeutics Earnings Forecast
Key Cidara Therapeutics Financial Ratios
- The Gross Profit Margin over the past 5 years for CDTX is 97.62%.
- The Selling, General & Administrative Expenses for CDTX have been equal to 28.69% of Gross Profit Margin.
- The Research & Development expenses have been 107.24% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 11 years have been positive in 6 years.
Cidara Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CDTX |
CUSIP: | 171757 |
Website: | cidara.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CDTX Technical Analysis vs Fundamental Analysis
Buy
81
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a Buy
The current Cidara Therapeutics [CDTX] share price is $17.45. The Score for CDTX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.